Cancer Institute Membership Policy

Membership Criteria

Membership in the Samuel Oschin Comprehensive Cancer Institute is available to Cedars-Sinai faculty and medical staff who have an interest in cancer, delivery of cancer care, cancer-related research, clinical trials and training, and who meet the criteria outlined below. Members of other designated by the National Cancer Institute (NCI) centers are not eligible.


Member
To be eligible for full membership, one must be a member of the Cedars-Sinai faculty or medical staff, and satisfy one of the following requirements:

  • Holds current cancer research grants from the NC) or an NCI-approved peer-review agency or organization (see list below) as principal investigator (PI)
  • Has a consistent history of NCI-approved peer-reviewed extramural funding (as PI or co-PI) and publications in cancer-related research in the past three years
  • Conducts clinical research as a PI of the Cedars-Sinai Institutional Review Board (IRB) and the institution's IRB-approved interventional clinical trials
  • Holds a cancer institute-level leadership position in research programs, committees or shared resources, and contributes to the research objectives in important ways that lead to furthering the institute's research mission


Clinical Program Member
Clinical program members are Cedars-Sinai faculty and medical staff who are primarily dedicated to cancer patient care. Clinical program members do not need to have academic contributions and accordingly are not eligible for inclusion in a P30 Cancer Center Support Grant (CCSG) for NCI designation.


Associate Member
An associate member must be part of the Cedars-Sinai faculty or medical staff and satisfy one of the following requirements:

  • Within the past three years, has submitted a competitive cancer-related grant application and is a lead author (first or senior) of a peer-reviewed cancer-related publication
  • Is a newly recruited faculty member or an established investigator new to cancer research who is applying for independent competitive cancer-related funding
  • Contributes to clinical cancer research as a co-investigator of the Cedars-Sinai IRB and the institution's IRB-approved clinical trials, or substantially contributes to the research as a key collaborator (for example, procures clinical specimens, provides diagnostic expertise, directs laboratory experiments, etc.)


Member in Training
Members in training are postdoctoral fellows, project scientists or clinical fellows engaging at least 80 percent effort in cancer research/care. Members in training are not eligible for inclusion in a P30 CCSG for NCI designation.

Android app on Google Play